Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Manis

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Nature Medicine|March 27, 2019
Highly efficient therapeutic gene editing of human hematopoietic stem cellsYuxuan Wu, Jing Zeng, Benjamin P Roscoe, et al.
Med (New York, N.Y.)|February 28, 2025
A progranulin variant causing childhood interstitial lung disease responsive to anti-TNF-α biologic therapyJohn C Kennedy, Sara O Vargas, Martha P Fishman, et al.
The Journal of Clinical Investigation|November 2, 2016
Deficiency of base excision repair enzyme NEIL3 drives increased predisposition to autoimmunityMichel J Massaad, Jia Zhou, Daisuke Tsuchimoto, et al.
Blood|June 3, 2026
Long-term stability of posttranscriptional genetic silencing of BCL11A using a shmiR vector in Sickle Cell DiseaseErica B Esrick, Leslie Lehmann, Amy Federico, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Gene editing without <i>ex vivo</i> culture evades genotoxicity in human hematopoietic stem cellsJing Zeng, My Anh Nguyen, Pengpeng Liu, et al.
Cell Stem Cell|December 13, 2024
Gene editing without ex vivo culture evades genotoxicity in human hematopoietic stem cellsJing Zeng, My Anh Nguyen, Pengpeng Liu, et al.
Frontiers in Immunology|October 19, 2017
Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56<sup>bright</sup> NKG2A<sup>+++</sup> Cells, and Yet Display Increased Degranulation and Higher Perforin ContentKerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.
Frontiers in Immunology|August 4, 2017
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56<sup>bright</sup> NKG2A<sup>+++</sup> Cells, and Yet Display Increased Degranulation and Higher Perforin ContentKerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Nature Medicine|March 27, 2019
Highly efficient therapeutic gene editing of human hematopoietic stem cellsYuxuan Wu, Jing Zeng, Benjamin P Roscoe, et al.
Med (New York, N.Y.)|February 28, 2025
A progranulin variant causing childhood interstitial lung disease responsive to anti-TNF-α biologic therapyJohn C Kennedy, Sara O Vargas, Martha P Fishman, et al.
The Journal of Clinical Investigation|November 2, 2016
Deficiency of base excision repair enzyme NEIL3 drives increased predisposition to autoimmunityMichel J Massaad, Jia Zhou, Daisuke Tsuchimoto, et al.
Blood|June 3, 2026
Long-term stability of posttranscriptional genetic silencing of BCL11A using a shmiR vector in Sickle Cell DiseaseErica B Esrick, Leslie Lehmann, Amy Federico, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Gene editing without <i>ex vivo</i> culture evades genotoxicity in human hematopoietic stem cellsJing Zeng, My Anh Nguyen, Pengpeng Liu, et al.
Cell Stem Cell|December 13, 2024
Gene editing without ex vivo culture evades genotoxicity in human hematopoietic stem cellsJing Zeng, My Anh Nguyen, Pengpeng Liu, et al.
Frontiers in Immunology|October 19, 2017
Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56<sup>bright</sup> NKG2A<sup>+++</sup> Cells, and Yet Display Increased Degranulation and Higher Perforin ContentKerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.
Frontiers in Immunology|August 4, 2017
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56<sup>bright</sup> NKG2A<sup>+++</sup> Cells, and Yet Display Increased Degranulation and Higher Perforin ContentKerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.
Pageof 6